Not Tagged
day one biopharmaceutical,arcus biosciences,immunogen,replimune
['ovarian', '$repl', '$rcus', '$dawn', '$imgn']
#asco2023 monday morning roundup: $imgn and $dawn are on the rise following news in ovarian cancer and pediatric gliomas. $repl jumps on skin cancer update, while tigit update slams $rcus. 
Biopharma and medtech reporter for Investor's Business Daily, @IBDinvestors. @Cronkite_ASU alumna, taco connoisseur and twin mom. She/her.